Where the Money Goes

You are here

Northwestern Mutual Foundation

The mission of the Northwestern Mutual Foundation is to improve the lives of children and families in need. The Foundation has given more than $35 million since its inception in 1992 and is designed to create lasting impact in the communities where the company's employees and financial representatives live and work. We accomplish this by combining financial support, volunteerism, thought leadership and convening community partners to deliver the best outcomes. Our efforts are focused nationally on curing childhood cancer, and locally on education, neighborhoods and making our hometown of Milwaukee a great destination.

Co-Funded Projects

Project Title Institutions Co-Funder(s)
Epigenetic Targeting of Translation in Sarcomas Seattle Children’s Hospital Northwestern Mutual Foundation
Investigating interactions between the oncogenic phosphatase PPM1D and oncohistone H3K27M in diffuse midline gliomagenesis Duke University Northwestern Mutual Foundation
Targeting Fatty Acid Oxidation as a Metabolic Vulnerability in Pediatric Cancers Dana-Farber Cancer Institute Northwestern Mutual Foundation
Identifying mechanisms of revumenib resistance in KMT2A-r pediatric acute myeloid leukemia (AML) The Johns Hopkins University School of Medicine Northwestern Mutual Foundation
The immunosuppressive role of thrombospondin-2 in pulmonary metastatic osteosarcoma Children’s Hospital Los Angeles Northwestern Mutual Foundation
Targeting Chromatin Remodelers to Enhance Neuroblastoma Differentiation Therapy Dana-Farber Cancer Institute Northwestern Mutual Foundation
Elucidating Essential Kinase-Independent Functions of ALK Children’s Hospital of Philadelphia Northwestern Mutual Foundation
Novel Synergistic Drug Combinations for Lineage-plastic Pediatric Leukemias The Johns Hopkins University School of Medicine Northwestern Mutual Foundation
Social Determinants of Health Associated with Clinical Trial Enrollment in a Diverse Cohort of Children and Adolescents with Acute Lymphoblastic Leukemia University of California, San Diego Northwestern Mutual Foundation
Lipid nanoparticle delivery of CRISPR/Cas9 reagents for disruption of oncogenic translocations in alveolar rhabdomyosarcoma University of California, Los Angeles Northwestern Mutual Foundation

Pages